Johnson & Johnson (JNJ) EBT (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of EBT data on file, last reported at $6.0 billion in Q1 2026.

• Quarterly EBT fell 56.06% year-over-year to $6.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 billion (down 6.25% YoY) and the FY2025 annual result came in at $32.6 billion, up 95.25% from the prior year.
• EBT advanced to $6.0 billion in Q1 2026 per JNJ's latest filing, from $5.0 billion in the prior quarter.
• The five-year high for EBT was $13.6 billion in Q1 2025, with the low at -$1.3 billion in Q2 2023.
• Average EBT over 5 years is $5.3 billion, with a median of $5.2 billion recorded in 2022.
• Year-over-year, EBT slumped 124.74% in 2023 and surged 388.58% in 2024.
• Johnson & Johnson's EBT stood at $5.2 billion in 2022, then dropped by 6.69% to $4.8 billion in 2023, then retreated by 19.46% to $3.9 billion in 2024, then gained by 27.76% to $5.0 billion in 2025, then advanced by 20.62% to $6.0 billion in 2026.
• Business Quant data shows JNJ's EBT at $6.0 billion in Q1 2026, $5.0 billion in Q4 2025, and $7.5 billion in Q3 2025.